Keywords: Vaccines, Markets, Forecasts

Global vaccines market forecast to grow to $34 billion by 2012

Article | 24 December 2009

Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry, according to a new report added to the offering of Research and Markets. Overall, the global vaccine market is expected to register revenues in excess of $34 billion by 2012.

With a projected compound annual growth rate (CAGR) of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in